The development of new non-nucleoside reverse transcriptase inhibitors (NNRTIs) is an efficient strategy for finding new therapeutic agents against human immunodeficiency virus (HIV). A large number of 6-substituted uracil derivatives have been prepared in order to explore new NNRTIs. However, there are few approaches to anti-HIV agents from 1,3-disubstituted uracil derivatives. Therefore, we tried to prepare several 1,3-disubstituted uracils, which were easily obtainable from uracil by preparation under alkali and Mitsunobu conditions, and examined their antiviral activity against HIV-1 and human cytomegalovirus (HCMV). We found that 1-benzyl-3-(3,5-dimethylbenzyl)uracil and 1-cyanomethyl-3-(3,5-dimethylbenzyl)-4-thiouracil showed powerful inhibition against HCMV and HIV-1, respectively.
BabaMTanakaHDe ClercqEPauwelsRBalzariniJScholsDNakashimaHPernoC-FWalkerRT & MiyasakaT (1989) Highly specific inhibition of human immunodeficiency virus type 1 by a novel 6-substituted acyclouridine derivative. Biochemical & Biophysical Research Communications165: 1375–1381.
2.
BabaMDe ClercqETanakaHUbasawaMTakashimaHSekiyaKNittaIUmezuKNakashimaHMoriSShigetaSWalkerRT & MiyasakaT (1991) Potent and selective inhibition of human immunodeficiency virus type 1 (HIV-1) by 5-ethyl-6-phenylthiouracil derivatives through their interaction with the HIV-1 reverse transcriptase. Proceedings of the National Academy of Sciences, USA88: 2356–2360.
BuckheitRWJrWatsonKFliakas-BoltzVRussellJLoftusTLOsterlingMCTurpinJAPallanschLAWhiteELLeeJWLeeSHOhJWKwonHSChungSG & ChoEH (2001) SJ-3366, a unique and highly potent nonnucleoside reverse transcriptase inhibitor of human immunodeficiency virus type 1 (HIV-1) that also inhibits HIV-2. Antimicrobial Agents & Chemotherapy45: 393–400.
5.
ClivioPFourreyJ-LGascheJ & FavreA (1992) Synthesis of deoxydinucleoside phosphates containing 4-thio substituted pyrimidine nucleobases. Journal of the Chemical Society (Prekin Tr ansactions)1: 2383–2388.
6.
ClivioP & FourreyJ-L (1994) Photoaffinity of di(deoxyribonucleoside) methyl-phophonates containing N3-methyl-4-thiothymidine. Journal of Organic Chemistry59: 7273–7283.
7.
De ClercqE (1995) Antiviral therapy for Human Immunodeficiency virus infections. Clinical Microbiology Reviews8: 200–239.
8.
De ClercqE (1996) Non-nucleoside reverse transcriptase inhibitors (NNRTIs) for the treatment of human immunodeficiency virus type 1 (HIV-1) infections: Strategies to overcome drug resistance development. Medicinal Research Reviews16: 125–157.
9.
De ClercqE (1996) What can be expected from non-nucleoside reverse transcriptase inhibitors (NNRTIs) in the treatment of human immunodeficiency virus type 1 (HIV-1) infections?Reviews in Medical Virology6: 97–117.
10.
FoxJJPraagDVWempenIDoerrILCheongLKnollJEEidinoffMLBendichA & BrownGB (1959) Thiation of nucleosides. II. Synthesis of 5-methyl-2′-deoxycytidine and related pyrimidine nucleosides. Journal of the American Chemical Society81: 178.
11.
GrangierGAitkenDJGuillaumeDTomasAViossatB & HussonH-P (1994) Reactivity of nucleophilic uracil derivatives. Journal of Heterocyclic Chemistry31: 1707–1714.
12.
HilbertGE & JohnsonTB (1930) Reserches on pyrimidines. CXV. Alkylation on nitrogen of the pyrimidine cycle by application of a new technique involving molecular rearrangements. Journal of the American Chemical Society52: 2001–2007.
13.
IshikawaIItohTTakayanagiHOshimaJKawaharaNMizunoY & OguraH (1991) The photocycloaddition reactions of uridine and related compounds with 2,3-dimethyl-2-butene. Chemical & Pharmaceutical Bulletin39: 1922–1930.
14.
KozaiSFukagawaT & MaruyamaT (1998) A new method for the synthesis of N3-alkylated analogs of 5-fluorouracil. Journal of the Chemical Society Prekin Transactions1: 3145–3146.
15.
LazrekHBTaourirteMOulihTKabbajYBarascutJLImbachJLAlmasoudiN & PfleidererW (1997) Synthesis of 3′-deoxy-3′ and 5′-deoxy-5-[4-purin-9-yl/pyrimidin-1-yl)methyl-1,2,3-triazol-1-yl]thymidine via 1,3-dipolar cycloaddition. Nucleosides & Nucleotides16: 1073–1077.
16.
MaiAArticoMSbardellaGMassaSNovellinoEGrecoGLoiAGTramontanoEMarongiuME & La CollaP (1999) 5-Alkyl-2-(alkylthio)-6-(2,6-dihalophenyl-methyl)-3,4-dihydropyrimidin-4(3H)-ones: Novel potent and selective dihydro-alkoxy-benzyloxopyrimidine derivatives. Journal of Medicinal Chemistry42: 619.
17.
MaruyamaTKozaiS & UchidaM (1999) Synthesis of N-aryl uracils and hypoxanthines and their biological properties. Nucleosides & Nucleotides18: 661–671.
18.
MaruyamaTFujiwaraK & FukuharaM (1995) A new method for the synthesis of N-phenyl uracil and pyrimidine nucleosides. Journal of the Chemical Society (Prekin Transactions)1: 733–734.
19.
MitsunobuO (1981) The use of diethyl azodicarboxylate and triphenylphosphine in synthesis and transformation of natural products. Synthesis1–28.
20.
NoellCW & ChengCC (1978) 1-(Tetrahydro-2-furyl)pyrimidines. Nucleic Acid Chemistry. Edited by TipsonRS & TownsendLBNew York, John Wiley & Sons, pp 57–66.
21.
NugentRASchlachterSTMurphyMJCleekGJPoelTJWishkaDGGraberDRYagiYKeiserBJOlmstedRAKoptaLASwaneySMPoppeSMMorrisJTarpleyWG & ThomasRC (1998) Pyrimidine thioethers: A novel class of HIV-1 reverse transcriptase inhibitors with activity against BHAP-resistant HIV. Journal of Medicinal Chemistry41: 3793–3803.
22.
PedersenOS & PedersenEB (2000) The floursishing syntheses of non-nucleoside reverse transcriptase inhibitors. Synthesis479–495.
23.
SinghHAggarwalP & KumarS (1980) A facile synthesis of 1-monosubstituted and unsymmetrically 1,3-disubstituted uracils. Synthesis520.
24.
SyperLSkrowaczewskaZ & BytnarA (1967) Rearrangements of 2,4,6-collidine N-oxide under the action of acetic anhydride. Roczniki Chemii41: 1027–1035.
25.
SzczechGMFurmanPPainterGRBarryDWBorroto-EsodaKGrizzleTBBlumMRSommadossiJ-PEndohRNiwaTYamamotoM & MoxhamC (2000) Safety assessment, in vitro and in vivo, and pharmacokinetics of emivirine, a potent and selective nonnucleoside reverse transcriptase inhibitor of human immunodeficiency virus type 1. Antimicrobial Agents & Chemotherapy44: 123–130.
